tiprankstipranks
Trending News
More News >
RAPT Therapeutics (RAPT)
NASDAQ:RAPT
US Market

RAPT Therapeutics (RAPT) Income Statement

Compare
425 Followers

RAPT Therapeutics Income Statement

Last quarter (Q3 2025), RAPT Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, RAPT Therapeutics's net income was $-17.58M. See RAPT Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 1.53M$ 3.81M$ 5.04M
Gross Profit
$ 0.00$ 0.00$ 1.53M$ 3.81M$ 5.04M
Operating Expenses
$ 136.10M$ 127.06M$ 87.32M$ 73.02M$ 58.26M
Depreciation and Amortization
$ 1.20M$ 1.22M$ 1.05M$ 996.00K$ 1.12M
EBITDA
$ -134.90M$ -125.85M$ -84.75M$ -68.21M$ -52.09M
Operating Income
$ -136.10M$ -127.06M$ -85.80M$ -69.21M$ -53.21M
Other Income/Expenses
$ 6.24M$ 10.26M$ 1.96M$ 5.00K$ 1.31M
Pretax Income
$ -129.87M$ -116.80M$ -83.84M$ -69.20M$ -51.90M
Net Income
$ -129.87M$ -116.80M$ -83.84M$ -69.20M$ -52.89M
Per Share Metrics
Basic EPS
$ -25.49$ -24.37$ -20.61$ -20.21$ -17.53
Diluted EPS
$ -25.49$ -24.37$ -20.61$ -20.21$ -17.53
Weighted Average Shares Outstanding
5.10M 4.79M 4.07M 3.42M 3.02M
Weighted Average Shares Outstanding (Diluted)
5.10M 4.79M 4.07M 3.42M 3.02M
Currency in USD

RAPT Therapeutics Earnings and Revenue History